Eledon Pharmaceuticals Stock Quote ELDN - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

2.835

Bid

2.82

Ask

2.84

Volume

223,036

2.50 Day's Range 2.85

1.07 52 Week Range 2.85

Market Cap

63.641M

Previous Close

2.505

Open

2.50

Last Trade

1692

2.835

Last Trade Time

10:58:50

Financial Volume

$ 584,214

VWAP

2.6194

Average Volume (3m)

163,959

Shares Outstanding

24,198,130

Dividend Yield

PE Ratio

-1.58

Earnings Per Share (EPS)

-1.67

Revenue

Net Profit

-40.33M

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for... Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's lead compound in development is AT-1501 which is the next generation anti-CD40L antibody. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.eledon.com

Headquarters

Dover, Delaware, USA

Founded

1970

Eledon Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ELDN. The last closing price for Eledon Pharmaceuticals was $2.51. Over the last year, Eledon Pharmaceuticals shares have traded in a share price range of $ 1.07 to $ 2.85.

Eledon Pharmaceuticals currently has 24,198,130 shares outstanding. The market capitalization of Eledon Pharmaceuticals is $63.64 million. Eledon Pharmaceuticals has a price to earnings ratio (PE ratio) of -1.58.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results

Completed oversubscribed $50 million private placement First participant dosed in clinical trial at University of Chicago Medicine assessing the use of tegoprubart to prevent islet cell transplant...

Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress

IRVINE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that the Company will participate in the American Transplant Congress...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.405	16.6666666667	2.43	2.85	2	177150	2.33146998	CS
4	1.285	82.9032258065	1.55	2.85	1.55	312432	2.23112016	CS
12	1.015	55.7692307692	1.82	2.85	1.5199	163959	2.09177388	CS
26	1.615	132.37704918	1.22	2.85	1.1099	114643	1.94180048	CS
52	0.535	23.2608695652	2.3	2.85	1.07	104516	1.77641951	CS
156	-6.165	-68.5	9	10.2	1.07	78062	3.09971455	CS
260	-12.965	-82.0569620253	15.8	22.91	1.07	75982	4.05443898	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
LSDILucy Scientific Discovery Inc	$ 1.56 (205.88%)	47.95M
GWAVGreenwave Technology Solutions Inc	$ 0.146 (144.15%)	773.45M
CRKNCrown Electrokinetics Corporation	$ 0.103 (122.94%)	487.86M
PEGYPineapple Energy Inc	$ 0.1665 (91.60%)	257.36M
FFIEFaraday Future Intelligent Electric Inc	$ 1.21 (71.63%)	497.46M
INVZWInnoviz Technologies Ltd	$ 0.185 (-32.73%)	1.53k
LGHLWLion Group Holding Ltd	$ 0.0041 (-28.07%)	40
EYENEyenovia Inc	$ 0.827 (-21.98%)	688.61k
RELIReliance Global Group Inc	$ 0.2985 (-19.30%)	1.33M
OMEROmeros Corporation	$ 3.375 (-19.06%)	544.29k
GWAVGreenwave Technology Solutions Inc	$ 0.146 (144.15%)	773.46M
FFIEFaraday Future Intelligent Electric Inc	$ 1.20 (70.21%)	497.49M
CRKNCrown Electrokinetics Corporation	$ 0.1038 (124.68%)	487.99M
PEGYPineapple Energy Inc	$ 0.1662 (91.25%)	257.48M
CYNCYNGN Inc	$ 0.1336 (55.71%)	198.69M